| Item | Value |
|---|---|
| DrugBank ID | DB00531 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 14 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | retinoblastoma | TxGNN Knowledge Graph |
| 2 | lymphoma | TxGNN Knowledge Graph |
| 3 | neuroblastoma | TxGNN Knowledge Graph |
| 4 | breast carcinoma | TxGNN Knowledge Graph |
| 5 | mycosis fungoides and variants | TxGNN Knowledge Graph |
| 6 | breast neoplasm | TxGNN Knowledge Graph |
| 7 | lymphosarcoma | TxGNN Knowledge Graph |
| 8 | primary cutaneous T-cell lymphoma | TxGNN Knowledge Graph |
| 9 | plasma cell myeloma | TxGNN Knowledge Graph |
| 10 | folliculotropic mycosis fungoides | TxGNN Knowledge Graph |
| 11 | localized pagetoid reticulosis | TxGNN Knowledge Graph |
| 12 | retinal neuroblastoma | TxGNN Knowledge Graph |
| 13 | granulomatous slack skin disease | TxGNN Knowledge Graph |
| 14 | primary central nervous system lymphoma | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.